ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
243.13
-1.68 (-0.69%)
Jan 5, 2026, 9:42 AM EST - Market open
ResMed Stock Forecast
Stock Price Forecast
The 11 analysts that cover ResMed stock have a consensus rating of "Buy" and an average price target of $289.09, which forecasts a 18.90% increase in the stock price over the next year. The lowest target is $260 and the highest is $330.
Price Target: $289.09 (+18.90%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 6 | 6 | 6 | 6 | 7 | 6 |
| Hold | 3 | 3 | 3 | 4 | 4 | 5 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $270 → $260 | Hold | Maintains | $270 → $260 | +6.94% | Dec 18, 2025 |
| Baird | Baird | Buy → Hold Downgrades $300 → $275 | Buy → Hold | Downgrades | $300 → $275 | +13.11% | Dec 16, 2025 |
| Baird | Baird | Buy Maintains $320 → $300 | Buy | Maintains | $320 → $300 | +23.39% | Nov 3, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $300 → $303 | Buy | Maintains | $300 → $303 | +24.62% | Oct 31, 2025 |
| Keybanc | Keybanc | Buy Maintains $298 → $299 | Buy | Maintains | $298 → $299 | +22.98% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
5.65B
from 5.15B
Increased by 9.85%
Revenue Next Year
6.07B
from 5.65B
Increased by 7.36%
EPS This Year
10.98
from 9.51
Increased by 15.48%
EPS Next Year
12.14
from 10.98
Increased by 10.58%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.0B | 6.5B | |||
| Avg | 5.7B | 6.1B | |||
| Low | 5.4B | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.6% | 14.6% | |||
| Avg | 9.8% | 7.4% | |||
| Low | 5.4% | 2.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.80 | 13.29 | |||
| Avg | 10.98 | 12.14 | |||
| Low | 10.14 | 11.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 24.1% | 21.0% | |||
| Avg | 15.5% | 10.6% | |||
| Low | 6.7% | 3.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.